Papers/PMID:19179490
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
American journal of respiratory and critical care medicine2009The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
calciol — no detected effect on all-cause mortality
Evidence strength: very limited.FindingNull resultreplicated ×5“Overall mortality was 15% (54 of 365) at 1 year of follow-up and similar in both arms (30 of 187 for vitamin D treated and 24 of 178 for placebo; relative risk, 1.19 [0.58-1.95]).”
Quoted verbatim from Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.. - Study
- RCT
- Participants
- 365
- Duration
- 12 months
- Dose
- 100,000 IU cholecalciferol at inclusion and again 5 and 8 months after start of treatment
- Population
- Adult patients with tuberculosis starting antituberculosis treatment in Guinea-Bissau; 12-month mortality
Effect 1.19 risk ratio, 95% CI 0.58 to 1.95
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.2009PMID:1917949010.1164/rccm.200804-567OCPermalink